Clinical Heart Failure Among Patients With and Without Severe Mental Illness and the Association With Long-Term Outcomes.


Journal

Circulation. Heart failure
ISSN: 1941-3297
Titre abrégé: Circ Heart Fail
Pays: United States
ID NLM: 101479941

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 1 10 2021
medline: 22 12 2021
entrez: 30 9 2021
Statut: ppublish

Résumé

Patients with severe mental illness (SMI) including schizophrenia, bipolar disorder, and severe depression have earlier onset of cardiovascular risk factors, predisposing to worse future heart failure (HF) compared with the general population. We investigated associations between the presence/absence of SMI and long-term HF outcomes. We identified patients with HF with and without SMI in the Duke University Health System from 2002 to 2017. Using multivariable Cox regression, we examined the primary outcome of all-cause mortality. Secondary outcomes included rates of implantable cardioverter defibrillator use, cardiac resynchronization therapy, left ventricular assist device implantation, and heart transplantation. We included 20 906 patients with HF (SMI, n=898; non-SMI, n=20 008). Patients with SMI presented clinically 7 years earlier than those without SMI. We observed an interaction between SMI and sex on all-cause mortality ( SMI was associated with adverse HF outcome among men and not women. Despite equal access to procedures for HF between patients with and without SMI, those with SMI experienced excess postprocedural mortality. Our data highlight concurrent sex- and mental health-related disparities in HF prognosis, suggesting that patients with SMI, especially men, merit closer follow-up.

Sections du résumé

BACKGROUND
Patients with severe mental illness (SMI) including schizophrenia, bipolar disorder, and severe depression have earlier onset of cardiovascular risk factors, predisposing to worse future heart failure (HF) compared with the general population. We investigated associations between the presence/absence of SMI and long-term HF outcomes.
METHODS
We identified patients with HF with and without SMI in the Duke University Health System from 2002 to 2017. Using multivariable Cox regression, we examined the primary outcome of all-cause mortality. Secondary outcomes included rates of implantable cardioverter defibrillator use, cardiac resynchronization therapy, left ventricular assist device implantation, and heart transplantation.
RESULTS
We included 20 906 patients with HF (SMI, n=898; non-SMI, n=20 008). Patients with SMI presented clinically 7 years earlier than those without SMI. We observed an interaction between SMI and sex on all-cause mortality (
CONCLUSIONS
SMI was associated with adverse HF outcome among men and not women. Despite equal access to procedures for HF between patients with and without SMI, those with SMI experienced excess postprocedural mortality. Our data highlight concurrent sex- and mental health-related disparities in HF prognosis, suggesting that patients with SMI, especially men, merit closer follow-up.

Identifiants

pubmed: 34587762
doi: 10.1161/CIRCHEARTFAILURE.121.008364
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e008364

Auteurs

Christoffer Polcwiartek (C)

Division of Cardiology, Duke University Medical Center, Durham, NC (C.P., D.L., K.P.J., B.D.A.).
Department of Cardiology (C.P., K.K., C.T.-P., P.S., S.E.J.), Aalborg University Hospital, Denmark.
Department of Clinical Medicine (C.P., R.E.N., P.S., S.E.J.), Aalborg University, Denmark.

Daniel Loewenstein (D)

Division of Cardiology, Duke University Medical Center, Durham, NC (C.P., D.L., K.P.J., B.D.A.).
Department of Clinical Physiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden (D.L., K.G.J.).

Daniel J Friedman (DJ)

Section of Cardiac Electrophysiology, Yale School of Medicine, New Haven, CT (D.J.F.).

Karin G Johansson (KG)

Department of Clinical Physiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden (D.L., K.G.J.).

Claus Graff (C)

Department of Health Science and Technology (C.G., P.L.S.), Aalborg University, Denmark.

Peter L Sørensen (PL)

Department of Health Science and Technology (C.G., P.L.S.), Aalborg University, Denmark.
Department of Clinical Physiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden (D.L., K.G.J.).

René E Nielsen (RE)

Department of Psychiatry (R.E.N.), Aalborg University Hospital, Denmark.
Department of Clinical Medicine (C.P., R.E.N., P.S., S.E.J.), Aalborg University, Denmark.

Kristian Kragholm (K)

Department of Cardiology (C.P., K.K., C.T.-P., P.S., S.E.J.), Aalborg University Hospital, Denmark.

Christian Torp-Pedersen (C)

Department of Cardiology (C.P., K.K., C.T.-P., P.S., S.E.J.), Aalborg University Hospital, Denmark.
Department of Cardiology and Clinical Research, Nordsjællands Hospital, Hillerød, Denmark (C.T.-P.).

Peter Søgaard (P)

Department of Cardiology (C.P., K.K., C.T.-P., P.S., S.E.J.), Aalborg University Hospital, Denmark.
Department of Clinical Medicine (C.P., R.E.N., P.S., S.E.J.), Aalborg University, Denmark.

Svend E Jensen (SE)

Department of Cardiology (C.P., K.K., C.T.-P., P.S., S.E.J.), Aalborg University Hospital, Denmark.
Department of Clinical Medicine (C.P., R.E.N., P.S., S.E.J.), Aalborg University, Denmark.

Kevin P Jackson (KP)

Division of Cardiology, Duke University Medical Center, Durham, NC (C.P., D.L., K.P.J., B.D.A.).

Brett D Atwater (BD)

Division of Cardiology, Duke University Medical Center, Durham, NC (C.P., D.L., K.P.J., B.D.A.).
Section of Cardiac Electrophysiology, Inova Heart and Vascular Institute, Fairfax, VA (B.D.A.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH